IntuBrite Versus Macintosh for Endotracheal Intubation in Out of Hospital Cardiac Arrest

Sponsor
Medical University of Lodz (Other)
Overall Status
Completed
CT.gov ID
NCT05607836
Collaborator
(none)
86
1
2
77
1.1

Study Details

Study Description

Brief Summary

a randomized, parallel, non-blinded trial in a single Emergency Mdeical Service in Poland within a group of 34 ground ambulances crews, comparing time and first pass success (FPS) for endotracheal intubation (ETI) in DL using the IntuBrite® (INT) and Macintosh laryngoscope (MCL) during cardiopulmonary resuscitation (CPR). intubations will be performed using INT and MCL based on an intention-to-treat analysis. The FPS time of the ETI attempt will be analysed. First attempt success will be counted.

Condition or Disease Intervention/Treatment Phase
  • Device: IntuBrite intubation
  • Device: Macintosh laryngoscope
N/A

Detailed Description

Investigators designed a prospective observational study to compare INT (IntuBrite®, LLC; Vista, CA, USA) and MCL for ETI performed by paramedics in OHCA without an emergency physician on the scene. The main goal was to determine whether INT is superior to using an MCL laryngoscope during a tracheal intubation attempt in nontraumatic OHCA, in terms of time and effectiveness.

The time of intubation was measured using an electronic stopwatch. Time measurement began when the paramedic held the selected laryngoscope and declared their readiness to perform the procedure.

The effectiveness of the first ETI attempt for instrumental airway management for nontraumatic adult OHCA and end-tidal carbon dioxide monitoring was used to confirm correct device placement in all patients.

The degree difficulty of intubation attempts for all of the patients included in the study. A long-term survival and a cost-effectiveness analysis were not included within this trial.

The investigators will collect case report forms (CRFs) from patients after OHCA within a 40-month period.

The average professional experience of the paramedics in instrumental airway management will be noted (DL and LMA). The primary outcome is the FPS time of the ETI attempt performed by the paramedics.

The success rate on the first intubation attempt will be counted.

Study Design

Study Type:
Interventional
Actual Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Pilot, Prospective, Randomized Trial of IntuBrite Versus Macintosh Direct Laryngoscopy for Paramedic Endotracheal Intubation in Out of Hospital Cardiac Arrest
Actual Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Jan 1, 2020
Actual Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intu-Brite

Use of new laryngoscope - IntuBrite for intubation

Device: IntuBrite intubation
Use of new laryngoscope IntuBrite for intubation in patients with cardiopulmonary arrest and during resuscitation

Active Comparator: Macintosh

Use of standard laryngoscope with Macintosh blade for intubation

Device: Macintosh laryngoscope
Use of standard Macintosh blade laryngoscope for intubation in patients with cardiac arrest and requiring cardiopulmonary resuscitation

Outcome Measures

Primary Outcome Measures

  1. Intubation time [1 minute]

    Endotracheal intubation from grabbing device to placement of tube in the trachea confirmed by EtCO2

Secondary Outcome Measures

  1. Intubation success [1 minute]

    Endotracheal intubation confirmed with EtCO2

  2. intubation complications [5 minutes]

    intubation complications : esophageal intubation, injuries post intubation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients in cardiac arrest , requiring cardiopulmonary resuscitation
Exclusion Criteria:
  • suspected difficult intubation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Lodz, Poland Łódź Poland 90-153

Sponsors and Collaborators

  • Medical University of Lodz

Investigators

  • Principal Investigator: Tomasz Gaszynski, Medical University of Lodz, Poland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University of Lodz
ClinicalTrials.gov Identifier:
NCT05607836
Other Study ID Numbers:
  • RNN/06/20/KE
First Posted:
Nov 7, 2022
Last Update Posted:
Nov 7, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 7, 2022